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Abstract
Background: Major colorectal surgery usually requires a hospital stay of more than 12 days. Inadequate pain
management, intestinal dysfunction and immobilisation are the main factors associated with delay in recovery. The
present work assesses the short and medium term results achieved by an enhanced recovery program based on
previously published protocols.
Methods: This prospective study, performed at 12 Spanish hospitals in 2008 and 2009, involved 300 patients. All
patients underwent elective colorectal resection for cancer following an enhanced recovery program. The main
elements of this program were: preoperative advice, no colon preparation, provision of carbohydrate-rich drinks
one day prior and on the morning of surgery, goal directed fluid administration, body temperature control during
surgery, avoiding drainages and nasogastric tubes, early mobilisation, and the taking of oral fluids in the early
postoperative period. Perioperative morbidity and mortality data were collected and the length of hospital stay and
protocol compliance recorded.
Results: The median age of the patients was 68 years. Fifty-two % of the patients were women. The distribution of
patients by ASA class was: I 10%, II 50% and III 40%. Sixty-four % of interventions were laparoscopic; 15% required
conversion to laparotomy. The majority of patients underwent sigmoidectomy or right hemicolectomy. The overall
compliance to protocol was approximately 65%, but varied widely in its different components. The median length
of postoperative hospital stay was 6 days. Some 3% of patients were readmitted to hospital after discharge; some
7% required repeat surgery during their initial hospitalisation or after readmission. The most common
complications were surgical (24%), followed by septic (11%) or other medical complications (10%). Three patients
(1%) died during follow-up. Some 31% of patients suffered symptoms that delayed their discharge, the most
common being vomiting or nausea (12%), dyspnoea (7%) and fever (5%).
Conclusion: The following of this enhanced recovery program posed no risk to patients in terms of morbidity,
mortality and shortened the length of their hospital stay. Overall compliance to protocol was 65%. The following of
this program was of benefit to patients and reduces costs by shortening the length of hospital stay. The
implantation of such programmes is therefore highly recommended.
Background
Major colorectal surgery, i.e., surgery that involves wide
resection of the colon and anastomosis, generally
involves a prolonged hospital stay - on average 12-14
days. A stay of one week is usually the minimum that
can be expected [1]. This prolonged occupation of a
hospital bed is not usually owed to problems of
morbidity but to the conventional care protocol fol-
lowed. For decades this protocol has hardly been modi-
fied: it therefore does not take into account the
advances that have been made in the perioperative man-
agement of such patients.
Inadequate pain management, intestinal dysfunction
and immobilisation have been recognised since at least
1997 as among the main factors delaying postoperative
recovery in patients subjected to major surgery [2]. This
l e dK e h l e te ta l[ 3 ]t op r o p o s eas e r i e so fm e a s u r e s
designed to improve recovery following major colorectal
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gram. Currently, evidence-based multidisciplinary action
protocols of this kind, known initially as fast-track or
better called enhanced recovery programs (ERAS), are
not achieving the degree of implantation hoped for [3].
Some authors suggest this to be due to the organisa-
tional demands they make on surgeons, anaesthetists
and nursing staff, and to social, cultural and economic
realities [4].
The results that can be achieved with ERAS - reduc-
tions in postoperative morbidity, average length of hos-
pital stay and the consumption of resources - are,
however, significant, and the general implantation of an
ERAS for patients who are to undergo colorectal surgery
is recommendable [5-8]. In some of the clinical practice
guides available at http://www.reducinglengthofstay.org/,
these programmes are considered to represent best clin-
ical practice according to current scientific evidence.
Unfortunately, the results communicated regarding sur-
gery in an ERAS context have nearly all come from indi-
vidual institutions, although they include those of four
randomised clinical trial [5,9-11]. Recently the results of
an international study (five hospitals in different coun-
tries, four with no prior experience in ERAS) reporting
on patient follow-up, the degree of acceptance and the
degree of compliance with the protocol of a common
ERAS, have also become available [12]. The results of
these studies [5,9-12] suggest that just making a proto-
col available is insufficient for objectives to be achieved;
changes also need to be made to organisational strate-
gies and the medical professionals involved in pre, intra
and especially postoperative care require support, per-
haps via continuing education.
The present work analyses the short and medium
term results returned by an ERAS for colorectal surgery
based on previously published protocols, followed at 12
Spanish hospitals.
Methods
Participating centres
The twelve participating centres were chosen for their
organisational abilities and their experience and interest
in colorectal surgery and patient care. These centres,
distributed around Spain, ranged from large university
hospitals to medium and small area hospitals (the Clín-
ico from Zaragoza, La Paz, Clínico San Carlos and Gre-
gorio Marañón from Madrid, General from Valencia,
Mútua Terrassa, Do Meixoeiro from Vigo, Hospital
d’Igualada, La Mancha Centro from Alcázar de San
Juan, Universitario de Elche, Son Llatzer from Palma de
Mallorca and Fundación Calahorra hospitals) with the
collaboration of Health Technology Assessment Unit
from Agencia Laín Entralgo, Madrid.
There were two meetings with at least two profes-
sionals of each centre, a surgeon and an anaesthetist.
During these meetings discussions were held with
national and international experts who assisted the
group in the implementation of the program. These pro-
fessionals were the persons in charge to develop the
program in their centre and to starting the implementa-
tion of the protocol in two months after the second
work session. There were two annual reunions with the
group to supervise and improve the compliance of the
protocol.
Study design
This prospective study, which involved 300 patients, was
performed between 2008 and 2009. The ERAS used was
developed by the authors on the basis of published pro-
tocols [3,5,8-12]. The variables recorded included perio-
perative mortality, length of hospital stay and
compliance with the protocol.
The study was presented to the Hospital Ethical Board
and accepted as this is an observational non-randomised
study based on the best available evidence.
The research was conducted conformed to the Hel-
sinki Declaration and to local legislation. Patients gave
informed consent to participate in the study. This study
has been registered in the ISRCTN register with the
number ISRCTN16397735, you can also access to the
registration information by the URL: http://www.con-
trolled-trials.com/ISRCTN16397735.
Inclusion and exclusion criteria
A) Inclusion criteria. All patients had to be 18 years of
age or over and to be programmed for surgery for color-
ectal cancer without the need for a stoma or any further
surgical procedure.
B) Exclusion criteria: The need for emergency surgery,
an American Society of Anaesthesiologists (ASA) class
of IV, the need for a colostomy or ileostomy, the inabil-
ity to provide informed consent, diabetes, slow evacua-
tion previously documented by a digestive medicine
unit.
Enhanced recovery program protocol
The ERAS required that, during the preoperative period,
patients be given advice, that there be no preparation of
the colon and that patients receive four carbohydrate-
rich drinks (4 × 200 ml) one day prior to surgery plus
two further drinks (2 × 200 ml) on the morning of sur-
gery. During surgery, goal directed fluids were adminis-
tered using oesophageal Doppler monitoring, and
hypothermia and drainages avoided. After surgery, naso-
gastric tubes were not used, early mobilisation was prac-
tised, and oral fluids administered early. Table 1
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followed.
Although not explicitly required by the ERAS, the fol-
lowing variables were also recorded: opioid-free pain
control, the use of prophylactic medication for
postoperative vomiting and nausea, and the use of epi-
dural anaesthesia.
Patients were discharged following the criteria estab-
lished by the ERAS protocol. All patients were followed-
up for at least three months.
Table 1 Protocol characteristics of the followed enhanced recovery program
Time Procedure
Preoperative a. Provision of verbal and written information to patients regarding the ERAS. Collection of signed consent.
b. Malnourished patients to receive hyperproteic supplement at least twice per day during the week before surgery.
Day before surgery a. No colon preparation.
b. Normal food in the morning. Liquids on demand during the evening. Four bricks of carbohydrate-rich Nutricia Preop
®
to be taken during the evening (total: 800 ml).
c. Prophylaxis for pulmonary thromboembolism following normal practice.
d. Antibiotic prophylaxis following normal practice.
Day of surgery (before
surgery)
a. Two hours before surgery: provision of two bricks of Nutricia Preop
® (total: 400 ml).
b. Antibiotic prophylaxis.
Operating room A. Surgeons: no drainage; nasogastric tube, if needed, to be removed before extubation; if possible use transverse or
curved incisions in open surgery.
B Anaesthetists:
-Maintenance: Oxygen/air with FiO2 >80%.
-Monitoring: routine. Only use arterial/central catheter if unavoidable.
-Fluids: maintenance with Hartmann (5 cc/kg/h). Bolus of gelofusine (250 cc).
Maintain Hb > 8.0 g/dl.
- Optimise stroke volume via oesophageal Doppler:
-250 cc of fluid in bolus; if SV > 10% repeat until this figure is not reached. Provide no further bolus unless SV falls or
there is blood loss.
-If hypotension remains after SV correction, use a vasoconstrictor.
-Consider use of inotropic agents if peak velocity descends and clinical signs suggest ventricular function deficit.
-Temperature: use liquid heater and heating blanket.
Day of surgery (recovery
room)
-Mask with high oxygen flow for 2 h independent of saturation. Follow with nasal cannulae to maintain SpO2 > 95%.
-Maintain mean blood pressure >65 mmHg. If blood pressure low provide 250 cc gelofusine and reassess.
Day of surgery (ward) -In the evening sit patient in seat for at least 2 h.
-Liquid diet (800-1000 ml). Include two bricks of high protein/high calorie hospital dietary preparation (specific for
postoperative period).
-Minimum diuresis (500 cc in first 24 h).
-Analgesia: 1 g paracetamol/6 h.
Postoperative day 1 -Liquid diet, at least 2 l, including 3 bricks of high protein/high calorie hospital dietary preparation.
-Mobilisation; patient seated at least 6 h per day.
-Suspend IV fluid if tolerated. Heparin injection for maintaining patency of intermittent infusion devices.
-Maintain epidural analgesia pump if one in place.
-Paracetamol 1 g/6 h.
-Lactulose 1 sachet/12 h (preferably magnesium-based).
-Assess meeting of discharge criteria: only oral analgesia, mobilisation reaching presurgical level, toleration of solid food,
gases passed, stools passed, no nausea, and patient agrees to discharge.
Postoperative day 2 -Suspend epidural catheter; begin with NSAIDS; diet soft/normal; mobilisation on demand; remove urinary catheter and
assess meeting of discharge criteria.
Postoperative day 3 -Check general status; assess meeting of discharge criteria and take decision in this respect.
Follow up -Telephone monitoring for 48 h.
-First out-patient visit 10-14 days after surgery.
SV: stroke volume; IV: intravenous; Hb: haemoglobin.
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pared for the collection of data from the different centres.
Data analysis
Dichotomous variables were recorded as absolute fre-
quencies (number of cases) and relative frequencies
(percentages). It should be noted that this work reports
frequencies and percentages with respect to the data
made available; therefore they do not always refer to all
patients. Continuous variables were recorded as means
and standard deviations (SD) or median plus maximum
and minimum values, depending on whether or not
their distribution was normal (determined by the Kol-
mogorov-Smirnov test). All analyses were made using
18 version SPSS software.
Results
Patients, surgery and postoperative treatment
Of all patients who initially met criteria for inclusion, 16
were excluded, 9 patients were in intensive care at the
discretion of the anaesthetist and 7 received an
unscheduled ileostomy. A total of 300 patients were
finally included.
Table 2 shows the characteristic of the patients
included, the surgical techniques used and the surgical
procedures followed.
The median age of the patients was 69 years (35-88);
51.5% were women (152 patients). The patients were
distributed by ASA class as follows: I 10.2% (30), II
50.2% (148) and III 39.7% (117).
Some 63.6% (171) of the patients underwent laparo-
scopic surgery and 36.4% (98) open surgery. Some
15.3% of the laparoscopically intervened patients
required conversion to laparotomy (22).
Sigmoidectomy and right hemicolectomy made up the
majority of procedures performed (62.5%). Some 5.2% of
patients (15) were subjected to preoperative radiother-
apy. Laparotomy was medial in 88.8% and transversal in
11.2% of patients so intervened.
The mean preoperative hospital stay was 0.82 days
(SD: 1.93). The mean duration of surgery was 155.4
min. The median length of time spent in the recovery
room was 240 min (60-1500).
Main features of the protocol and their compliance rates
Table 3 shows the compliance rates for the main fea-
tures outlined in the ERAS protocol, as well as for the
other features not explicitly included in the protocol.
Table 2 Patient characteristics and surgical techniques
and procedures followed
Patients characteristics (n = 300) Values
Age (years) 69 35-88
Sex
Female 152 51.5
Male 143 48.5
Preoperative stay (days) 0.82 1.93
Surgical risk: ASA
I 30 10.2
II 148 50.2
III 117 39.7
Surgical technique
Laparoscopy 171 63.6
Conventional 98 36.4
Surgical procedure
Right hemicolectomy 98 35.6
Sigmoidectomy 74 26.9
Anterior resection 67 24.4
Left hemicolectomy 27 9.8
Transverse resection 5 1.8
Subtotal colectomy 4 1.5
Quantitative variables are expressed as medians plus minimum and maximum
values; qualitative variables are expressed as absolute numbers and
percentages. Preoperative stay is expressed as mean and standard deviation.
Table 3 Compliance with perioperative treatment and
postoperative recovery after colon resection within the
context of the enhanced recovery program followed
Perioperative treatment variable mentioned in ERAS protocol
Number Percentage
Preoperative
Perioperative information 290 99
No colon preparation 246 82.8
Carbohydrate-rich drinks on day before surgery
1 187 65.2
Carbohydrate -rich drinks before surgery
2 182 63
Surgery
Goal directed fluids (Cardio-Q)
3 138 46.3
No hypothermia 242 84.3
No drainage 146 53.3
Postoperative
No nasogastric tube 222 77.1
Early mobilisation 128 44.6
Early taking of fluids by mouth
4 116 40.6
Variable not explicitly mentioned in ERAS protocol
Number Percentage
Opioid-free pain control
5 206 78.3
Prophylactic medication for nausea and
vomiting
76 26.8
Epidural anaesthesia 106 38.8
1: 40.3% received two, 59.7% received three or four; 2: 14.8% received one,
85.2% received two; 3: Mean fluid volume received was 1742.5 ml; 4: 46.8%
received one, 50% received two, and 3.2% received more than two; 5: 42.8%
of patients used patient controlled analgesia.
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65%, but varied widely in its different components.
Postoperative hospital stay and readmission rate
The median length of postoperative hospital stay was 6
days (3-89 days). Figure 1 shows the distribution of
length of postoperative stay. The mean postoperative
length of stay according to surgical procedure was: right
hemicolectomy and sigmoidectomy 8 days, left hemico-
lectomy 6 days, and transverse resection and subtotal
colectomy 5 days.
Some 2.7% of the patients (8) were readmitted follow-
ing discharge for medical or surgical reasons. Three
patients re-presented with febrile syndrome, two with
nosocomial pneumonia, and three with pulmonary
thromboembolism, diarrhoea with hyponatremia or
abdominal wall abscess.
Some 7% of the patients (21) required repeat surgery.
The causes included dehiscence (12 patients), fistula or
anastomatic leakage (three patients), evisceration (two
patients), and abdominal pain, haemoperitoneum, ische-
mia and intestinal occlusion (one patient each). The
median post-repeat-operative length of hospital stay was
6 days (1-20).
Postoperative morbidity/mortality
Table 4 summarises the complications encountered. The
most common were surgical (23.7% of patients; 71), fol-
lowed by septic 11% (33) and other medical complica-
tions 9.7% (29). The most common surgical
complications were wound infection (12%; 36), paralytic
ileus (10%; 30; median paralysis time 3 days [2-8]), ana-
stomosis leakage (4.3%; 13) and perioperative haemor-
rhage (1.7%; 5). The most common medical
complications were respiratory distress (2.7%; 8),
respiratory failure (2.7%%; 8) and cardiac arrhythmia or
ischemia (1.7%; 5). Finally, the most common septic
complications were abdominal abscess (4.3%; 13), urine
infection (3.7%; 11), respiratory infection (3.7%; 11) and
peritonitis (2.3%; 7).
Three patients (1%), all of whom required repeat sur-
gery, died. Two of these died during their hospital stay
due to multi-organ failure and sepsis, and one from can-
cer following discharge.
Symptoms delaying discharge
Table 5 records the symptoms that delayed discharge.
Some 31.3% (94) of all patients presented some such
Figure 1 Length of postoperative stay of patients who
underwent colon surgery within the context of the present
enhanced recovery program.
Table 4 Local and general morbidity following colon
resection within the enhanced recovery program
followed
Total (n = 300) Number Percentage
Surgical complications 71 23.7
Wound infection 36 12
Paralytic ileus 30 10
Anastomosis leakage 13 4.3
Perioperative haemorrhage 5 1.7
Evisceration 3 1
Perforation 0 0
Other surgical complications 10 3.3
Septic complications 33 11
Abdominal abscess 13 4.3
Urine infection 11 3.7
Respiratory infection 11 3.7
Peritonitis 7 2.3
Sepsis 3 1
Catheter sepsis 2 0.7
Necrotising fascitis 0 0
Other septic complications 3 1
Medical complications 29 9.7
Respiratory distress 8 2.7
Respiratory failure 8 2.7
Cardiac complication 5 1.7
Pulmonary oedema 3 1
Acute urine retention 3 1
Pulmonary embolism 1 0.3
Myocardial infarction 0 0
Cerebrovascular accident 0 0
Venous thrombosis 0 0
Other medical complications 10 3.3
All complications 89 29.7
Mortality 3 1
Note: some patients presented more than one symptom.
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2.7% (8) suffered three, and 0.3% (1) suffered four. The
most common symptoms were vomiting (12%; 36), dys-
pnoea (6.7%; 20) and fever of unknown origin (4.7%; 14).
Discussion
Each of the steps outlined in the present ERAS is based
on scientific evidence. For example, patient education is
reported to be important in the response to surgery.
Now-classic studies [3] have shown that informed
patients require less analgesia in the postoperative per-
iod and indeed experience significantly less pain than
uninformed patients. More recent work has shown that
adequate preoperative information reduces patient anxi-
ety before surgery and may also hasten postsurgical
recovery [3,13,14].
A number of studies on programmed colon surgery
have brought into doubt the need for preoperative
mechanical cleansing of the intestine [3,15]. The need
for strict preoperative fasting has also been recently
questioned. Most clinical practice guides suggest a per-
iod of absolute fasting of between two and six hours,
but recent studies indicate that taking a carbohydrate-
rich drink before surgery may reduce the endocrine
catabolic response and improve insulin resistance [3,16],
improving surgical results and hastening recovery. The
present ERAS included the administration of carbohy-
drate-rich drinks (4 × 200 ml) one day prior to surgery
plus two further such drinks (2 × 200 ml) on the morn-
ing of surgery. The protocol also included the adminis-
tration of goal directed fluids made possible by the
standard use of oesophageal Doppler monitoring
[3,17-21], temperature control to avoid hypothermia [3],
and the non-routine use of a nasogastric tube; meta-
analyses of several trials suggest the latter may reduce
pulmonary complications [3,22]. A further measure was
the avoidance of routinely using drainage; several rando-
mised trials have suggested that drainage is of no benefit
[3,23,24]. Drainage can be avoided in most patients or
limited to a short period, facilitating early mobilisation
[3], a measure also called for by the ERAS followed.
Finally, although taking food orally is commonly limited
in the postoperative period, a number of studies have
shown that it is safe even after colon surgery involving
anastomosis [3,25,26]; it was therefore included in the
present ERAS.
Additional variables not explicitly included in the
ERAS were also measured: use of prophylactic medica-
tion for postoperative vomiting and nausea, use of epi-
dural anaesthesia [3], and opioid-free pain control, it has
been reported that opioid-free or opioid-reduced analge-
sia may hasten recovery [3].
When protocols such as the present are implanted, the
g o a li st h a tt h e r es h o u l db ef u l lc o m p l i a n c ew i t ha l l
measures outlined. However, full compliance is com-
monly very difficult to achieve [12]. In the present work
the overall compliance rate was 65%, but varied widely
in its different components. Patients received informa-
tion in nearly all cases, while compliance with the provi-
sion of early postoperative fluids seemed particularly
difficult.
The items of the protocol with less compliance were
early oral fluid administration, goal-directed fluid ther-
apy and early mobilization. The reason why these items
obtained different compliance with the protocol could
be the taste of oral fluid, rejection by patients, unavail-
ability of devices and temporary employment of some
healthcare providers involved in the ERAS. Probably the
implementation could improve involving and training all
the professionals who assist the patients included in the
protocol and identifying these patients with signboards
on bedside.
Missing values were most important for the variable
surgical approach with 6.2% of them, being lower in the
other variables.
The rates of complications and mortality recorded were
similar to those reported by other authors in randomized
controlled trials [5,8-11]. In the present work the most
common complication was wound infection. These pro-
grammes do not, therefore, appear to place the patient at
any extra risk. Our results are similar to previous multi-
center studies [27,28] in terms of surgical complications,
mortality and readmission rate. The surgical complica-
tion rate was 24% compared to the 14.1% reported by
Schwenk et al [27] and 20% reported by Braumann et al
[28]. The mortality rate was 1% compared to the 0.8%
reported by Schwenk et al [27] and 0,4% reported by
Braumann et al [28]. The readmission rate was 2.7%
compared to the 3.9% reported by Schwenk et al [27] and
4% reported by Braumann et al [28].
Table 5 Symptoms delaying discharge
Total (n = 300) Number of patients Percentage
Vomiting or nausea 36 12
Fatigue 20 6.7
Fever of unknown origin 14 4.7
Constipation 9 3
Dizziness 6 2
Pain 6 2
Urine retention 5 1.7
Depression, confusion 4 1.3
Diarrhoea 3 1
Scant diuresis 3 1
Other symptoms 26 8.7
Total 94 31.3
Note: some patients presented more than one symptom.
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with a preoperative hospital stay of fewer than 24 h and
an overall mean stay of 6 days. In other recently pub-
lished Spanish multicenter study, including data from 50
hospitals, the mean postoperative stay after colorectal
resection was 12.36 days [29].
Conclusion
The present ERAS posed no risk to patients in terms of
morbidity, mortality and shortened their hospital stay.
The present results show that these programmes can be
of benefit to patients and, by reducing hospital costs,
may benefit society as a whole.
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